Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab

“Evidence of the usefulness of cardiac biomarkers in cancer patients has been available for more than 20 years, but only recently have guidelines emerged regarding their use.”